UK Launches World's First Alzheimer's Prevention Drug Trial

The UK is launching a world-first clinical trial to test an Alzheimer's drug on middle-aged individuals who currently show no symptoms of the disease.

The study aims to determine if early intervention can prevent the onset of dementia, with participants aged 55 and older being recruited for the trial starting next week.

If successful, this approach could revolutionize dementia care by shifting the focus from symptom management to proactive prevention in high-risk populations.